Eur Spine J
GLP-1 medications increase sensitivity to sweet tastes, making heavily flavored or artificially sweetened products difficult to tolerate
Conclusion: This whole-exome analysis provides insights into the genetic characteristics of MVI in HCC patients, contributing to the understanding of the underlying molecular and physiological mechanisms and serving as a basis for targeted treatments for MVI
Consumption of diets with low advanced glycation end products improves cardiometabolic parameters: meta-analysis of randomised controlled trials
As the sector matures, the focus has apparently shifted from first-generation GLP-1 therapies toward differentiated approaches, including oral formulations, less frequent dosing schedules, improved body-composition outcomes such as lean muscle preservation, and next-generation mechanisms that combine GLP-1 with complementary pathways such as GIP, glucagon, and amylin
If you miss several doses in a row, speak to your prescriber before continuing